Latest Headlines
-
AustinPx Partners With Microsize On KinetiSol® Technology
1/31/2024
AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally delivered small molecule drug candidates, and Microsize, a leading active pharmaceutical ingredient enhancement CDMO, today announced the strategic partnership to accelerate the commercial application of AustinPx’s KinetiSol® Technology platform. The collaboration will enable AustinPx’s clients to manufacture their late-phase clinical and commercial KinetiSol drug product intermediate at Microsize’s purpose built, FDA-inspected facility.
-
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
1/30/2024
Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing process change resulting in a shorter manufacturing time for Yescarta® (axicabtagene ciloleucel). With this approval, Kite’s median turnaround time (TAT) in the U.S. is anticipated to be reduced from 16 days to 14 days. Median TAT is defined as time from leukapheresis, when a patient’s T cells are collected, to product release; manufacturing is
-
AbbVie Announces $223 Million Investment For New Biologics Manufacturing Facility In Singapore
1/29/2024
AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network.
-
INTEPRHEX Puts Hot-Topic Science In 2024 Event Registration Now Open | Event Program Now Online
1/22/2024
The reimagined INTERPHEX Conference is designed to bring attendees together to solve their business challenges and to understand the science that is shaping their industries.
-
Natoli Announces Tablet Manufacturing Training Schedule For 2024
1/18/2024
Natoli Engineering, a global leader in solid dose tooling, machinery, services, and support products, announces its extensive 2024 certified training schedule focused on enhancing the knowledge and refreshing scientific, manufacturing, and management skills. Natoli has a 40-year track record of training the industry using a practical and hands-on approach and is supported with classroom sessions and discussions.
-
Cleanroom Leader AES Clean Technology Announces New Chief Revenue Officer
1/18/2024
A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).
-
CDMO Rottendorf Pharma GmbH Adopts MES Software From Rockwell Automation
1/16/2024
Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced that as part of an ongoing company-wide digitalization program, Rottendorf Pharma GmbH is introducing the FactoryTalk PharmaSuite® manufacturing execution system from Rockwell Automation, a comprehensive electronic batch recording solution.
-
Emergent Biosolutions Awarded Procurement Contract Valued Up To $235.8 Million To Supply Biothrax® (Anthrax Vaccine Adsorbed) To The U.S. Department Of Defense
1/11/2024
Emergent BioSolutions Inc. has secured an indefinite-delivery, indefinite-quantity (IDIQ) procurement contract with a maximum value up to $235.8 million to supply BioThrax® (Anthrax Vaccine Adsorbed) for use by all branches of the U.S. military as Pre-Exposure Prophylaxis (PrEP) for anthrax disease.
- Virtual Pharma Expo Announces 2024 Webinar Series Schedule 12/28/2023
-
AST To Exhibit Aseptic Filling Technologies At Advanced Therapies Week
12/27/2023
AST has over 50 years of experience designing, manufacturing, and servicing innovative, high quality and highly automated processing equipment. Beginning in 2006, AST leveraged our experience and close customer relationships to revolutionize the aseptic fill/finish industry with the launch of the ASEPTiCell® development.